- Home
- WWW vs IRON Comparison
WWW vs IRON Comparison
Compare WWW & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- IRON
- Stock Information
- Founded
- WWW 1883
- IRON 2017
- Country
- WWW United States
- IRON United States
- Employees
- WWW N/A
- IRON N/A
- Industry
- WWW Shoe Manufacturing
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- IRON Health Care
- Exchange
- WWW Nasdaq
- IRON Nasdaq
- Market Cap
- WWW 2.5B
- IRON 2.1B
- IPO Year
- WWW N/A
- IRON N/A
- Fundamental
- Price
- WWW $30.67
- IRON $61.04
- Analyst Decision
- WWW Buy
- IRON Strong Buy
- Analyst Count
- WWW 6
- IRON 10
- Target Price
- WWW $29.67
- IRON $97.80
- AVG Volume (30 Days)
- WWW 1.6M
- IRON 290.0K
- Earning Date
- WWW 11-06-2025
- IRON 11-11-2025
- Dividend Yield
- WWW 1.30%
- IRON N/A
- EPS Growth
- WWW N/A
- IRON N/A
- EPS
- WWW 1.04
- IRON N/A
- Revenue
- WWW $1,821,400,000.00
- IRON N/A
- Revenue This Year
- WWW $7.52
- IRON N/A
- Revenue Next Year
- WWW $6.57
- IRON N/A
- P/E Ratio
- WWW $29.63
- IRON N/A
- Revenue Growth
- WWW N/A
- IRON N/A
- 52 Week Low
- WWW $9.58
- IRON $30.82
- 52 Week High
- WWW $32.80
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- WWW 60.25
- IRON 56.19
- Support Level
- WWW $29.37
- IRON $58.36
- Resistance Level
- WWW $31.46
- IRON $61.27
- Average True Range (ATR)
- WWW 0.95
- IRON 2.35
- MACD
- WWW -0.46
- IRON -0.10
- Stochastic Oscillator
- WWW 37.90
- IRON 38.82
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.